Michael Vitale delves into the process of commercialising Australian biotechnology, both the critical success factors and the obstacles, to paint a picture of the business reality for Australian emerging technology start-ups. Are the odds stacked against Australian biotech innovators? Or can they overcome the lack of capital, shortage of skilled management and inconsistent public policies...